Boehringer Ingelheim receives East Bay Innovation Award
- Details
- Category: Boehringer Ingelheim

Novartis expands cancer immunotherapy research program with acquisition of CoStim
- Details
- Category: Novartis

Crystal Bioscience and Boehringer Ingelheim announce multiple target antibody discovery collaboration
- Details
- Category: Boehringer Ingelheim

Pfizer and Merck to collaborate on innovative anti-cancer combination studies
- Details
- Category: Pfizer

Amgen and Merck announce collaboration To evaluate investigational combination treatment for advanced melanoma
- Details
- Category: Amgen

Bristol-Myers Squibb completes previously announced sale of global diabetes business to AstraZeneca
- Details
- Category: Bristol-Myers Squibb

Roche delivers strong 2013 results
- Details
- Category: Roche

More Pharma News ...
- UCB and Biogen Idec enter agreement to commercialize multiple sclerosis and hemophilia therapies in Asia
- Pfizer reports fourth-quarter and full-year 2013 results
- Novartis recognized among world's most sustainable companies in Corporate Knights Global 100
- Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results
- Abbott reports fourth-quarter and full-year 2013 results
- AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association's Pathway to Stop Diabetes
- Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation